NCT00142584
Evaluation of the Long-term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With Hypertension
See it on ClinicalTrials.gov ↗336 people
51.8%
48.2%
174 womenmiddle line = equal numbers162 men
- Phase
- PHASE3
- Paid for by
- Mylan Bertek Pharmaceuticals
- Finished
- 2008-03
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 50.6 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Black / African American 100%
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Recent myocardial infarction or stroke”
Study titles and rules are shown in their original English.